Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
Invesco S&P SmallCap Health Care ETF(PSCH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PSCH
10/28/2026: PSCH (2-star) is currently NOT-A-BUY. Pass it for now.
PSCH provides focused exposure to U.S. small-cap healthcare companies by tracking the S&P SmallCap 600 Capped Health Care Index. Its primary strength lies in offering a liquid and cost-efficient vehicle to gain access to the potentially high-growth biotechnology and medical device industries. It serves as an excellent satellite holding for growth-oriented portfolios seeking exposure to specific sector innovation. Investors should be aware of the inherent risks, including heightened volatility, sector concentration, and sensitivity to regulatory and interest-rate environments. It is best suited for long-term investors comfortable with cyclical fluctuations, rather than those seeking defensive income.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Small-cap healthcare companies offer significant growth potential through innovation and market expansion. |
| Momentum investor | Strong fit while signal remains positive | Small-cap healthcare often exhibits strong momentum during market cycles when risk appetite is high. |
| Value investor | Mixed fit | Small-cap healthcare often trades at premium valuations due to growth expectations rather than current earnings. |
| Dividend/Income investor | Weak fit | Most small-cap healthcare companies reinvest cash into R&D rather than paying significant dividends. |
| Low-risk investor | Weak fit | Small-cap healthcare is inherently volatile and not suitable for conservative or low-risk portfolios. |
Investor Profile
Ideal Investor Profile
The ideal investor is a growth-oriented individual seeking to tilt their portfolio toward small-cap healthcare innovation.
Suitability
Best suited for long-term growth investors who can tolerate high volatility; less appropriate for conservative income seekers or short-term traders without a clear thesis.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Small-cap healthcare stocks are susceptible to sharp price swings based on clinical results and regulatory news. |
| Market risk | Medium / high | The ETF is subject to overall equity market movements and specifically sector-wide health policy shifts. |
| Concentration | Medium / high | Limiting exposure to the small-cap healthcare niche reduces diversification compared to broad-market indices. |
| Tracking/expense | Low | The fund is efficiently managed with low tracking error relative to its underlying index. |
| Liquidity | Medium | Small-cap stocks can experience wider spreads and liquidity issues during periods of extreme market stress. |
| Business/sector quality | Medium | Small-cap firms often lack the diversified revenue streams of large-cap pharmaceutical giants. |
Risk Analysis
Volatility
PSCH exhibits higher-than-average beta compared to the broader S&P 500, characteristic of small-cap and biotech-heavy funds.
Market Risk
Risks include regulatory headwinds, clinical trial failure, and sensitivity to interest rate fluctuations affecting capital-intensive biotech firms.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Healthcare Equipment & Supplies | 35 | This segment provides exposure to medical device makers and supply companies that often drive sector innovation. |
| Industry | Biotechnology | 30 | Biotechnology stocks offer high growth potential but also higher volatility due to clinical trial and regulatory outcomes. |
| Industry | Healthcare Providers & Services | 20 | These companies provide essential services, offering a balance to more research-heavy firms in the portfolio. |
| Industry | Life Sciences Tools & Services | 10 | These firms support the broader pharmaceutical and biotech industry, providing stable research-related revenue. |
| Cash/collateral | Cash and Cash Equivalents | 5 | Small residual cash is held for liquidity and transaction settlement purposes. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 24.19% | Avg. Invested days 75 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | ETF Returns Performance  4.0 |
| Profits based on simulation | Last Close 10/28/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.